Diagnostic accuracy of Magnetic Resonance Imaging to differentiate benign and Malignant Parotid Gland Tumors
Journal Title: Journal of Radiology and Oncology - Year 2018, Vol 2, Issue 3
Abstract
Objective: To determine the diagnostic accuracy of Magnetic Resonance Imaging (MRI) to differentiate Benign and Malignant Parotid Gland Tumors taking histopathology as gold standard.
Authors and Affiliations
S Ali, Khan Adeena, K Sarfaraz, M Javaid, B Asma
Keywords
Related Articles
- EP ID EP536366
- DOI 10.29328/journal.jro.1001026
- Views 85
- Downloads 0
Adrenal insufficiency in Bilateral Adrenal Metastasis implemented SBRT
Today, there is a considerable increase in localizing adrenal bulks with the bringing radiologic diagnosis methods having high technology into use and improvement in diagnostic tests. Adrenal glands are vital tissues for...
Hyperthermia and Breast cancer: A short review
The main goal of hyperthermia is to elevate the tumor temperature to kill tumor cells and improve local control. The usage of hyperthermia is combination with radiotherapy or chemotherapy. Hyperthermia is delivered in di...
Investigation of radiation attenuation parameters of some drugs used in Chemotherapy in Wide Energy Region
Objectives: The aim of this study is to compute the radiation attenuation parameters such as mass attenuation coefficient, linear attenuation coefficient, half value layer, mean free path, and effective atomic number for...
A Short Synthesis Concerning Biological Effects and Equivalent Doses in Radiotherapy
The limits of classical equivalent computation based on time, dose, and fractionation (TDF) and linear quadratic models have been known for a long time. Medical physicists and physicians are required to provide fast and...
Near Complete Response to 177Lu-PSMA-DKFZ-617 Therapy in a Patient with Metastatic Castration Resistant Prostate Cancer
Prostate specific membrane antigen, a type II transmembrane protein is an excellent target for the radionuclide therapy in advanced prostate cancer patients due to its high expression in the prostate cancer cells. We pre...